Prognostic Relevance of Basal Cytokeratin Expression in Operable Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|69|6|478-485

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.6, 2006-02, pp. : 478-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Factors in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy: Towards a Quantification of Residual Disease

By  

Oncology, Vol. 88, Iss. 5, 2015-01 ,pp. : 261-272

Karger

Access to resources Recommend Favorite

Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

Prognostic Value of Syndecan-1 Expression in Breast Cancer

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 11-18

Karger

Access to resources Recommend Favorite

Prognostic Applications of Gene Expression Signatures in Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Clinical Relevance of Prognostic Factors in Axillary Node-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 438-445

Karger

Access to resources Recommend Favorite